{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:08:56Z","timestamp":1784880536636,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00277-018-3496-1","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T01:58:31Z","timestamp":1536890311000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome"],"prefix":"10.1007","volume":"98","author":[{"given":"Guillaume","family":"Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Givel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mariotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thi\u00e9blemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood.V126.23.1484.1484","volume":"126","author":"AM Perry","year":"2015","unstructured":"Perry AM, Jacques D, Nathwani BN et al (2015) Classification of non-Hodgkin lymphoma in seven geographic regions around the world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Blood 126:1484\u20131484","journal-title":"Blood"},{"key":"3496_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-Hodgkin lymphoma. Lancet Lond Engl 390:298\u2013310. https:\/\/doi.org\/10.1016\/S0140-6736(16)32407-2","journal-title":"Lancet Lond Engl"},{"key":"3496_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/1471-2334-14-512","volume":"14","author":"L Zafrani","year":"2014","unstructured":"Zafrani L, Azoulay E (2014) How to treat severe infections in critically ill neutropenic patients? BMC Infect Dis 14:512. https:\/\/doi.org\/10.1186\/1471-2334-14-512","journal-title":"BMC Infect Dis"},{"key":"3496_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","volume":"29","author":"E Azoulay","year":"2015","unstructured":"Azoulay E, P\u00e8ne F, Darmon M, Lenglin\u00e9 E, Benoit D, Soares M, Vincent F, Bruneel F, Perez P, Lemiale V, Mokart D, Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique (Grrr-OH) (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29:359\u2013367. https:\/\/doi.org\/10.1016\/j.blre.2015.04.002","journal-title":"Blood Rev"},{"key":"3496_CR5","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, P\u00e8ne F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study. J Clin Oncol Off J Am Soc Clin Oncol 31:2810\u20132818. https:\/\/doi.org\/10.1200\/JCO.2012.47.2365","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3496_CR6","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s00134-014-3480-8","volume":"40","author":"DD Benoit","year":"2014","unstructured":"Benoit DD, Soares M, Azoulay E (2014) Has survival increased in cancer patients admitted to the ICU? We are not sure. Intensive Care Med 40:1576\u20131579. https:\/\/doi.org\/10.1007\/s00134-014-3480-8","journal-title":"Intensive Care Med"},{"key":"3496_CR7","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol Off J Am Soc Clin Oncol 26:4124\u20134130. https:\/\/doi.org\/10.1200\/JCO.2008.16.4558","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3496_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1093\/annonc\/mdu443","volume":"25","author":"JS Abramson","year":"2014","unstructured":"Abramson JS, Feldman T, Kroll-Desrosiers AR, Muffly LS, Winer E, Flowers CR, Lansigan F, Nabhan C, Nastoupil LJ, Nath R, Goy A, Castillo JJ, Jagadeesh D, Woda B, Rosen ST, Smith SM, Evens AM (2014) Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Ann Oncol Off J Eur Soc Med Oncol 25:2211\u20132217. https:\/\/doi.org\/10.1093\/annonc\/mdu443","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"3496_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"3496_CR10","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1200\/JCO.2005.01.487","volume":"23","author":"G Thi\u00e9ry","year":"2005","unstructured":"Thi\u00e9ry G, Azoulay E, Darmon M, Ciroldi M, de Miranda S, L\u00e9vy V, Fieux F, Moreau D, le Gall JR, Schlemmer B (2005) Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol Off J Am Soc Clin Oncol 23:4406\u20134413. https:\/\/doi.org\/10.1200\/JCO.2005.01.487","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3496_CR11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, de Mendon\u00e7a A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine. Crit Care Med 26:1793\u20131800","journal-title":"Crit Care Med"},{"key":"3496_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G, for the Histiocyte Society (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"3496_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"3496_CR14","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3109\/10428194.2014.922181","volume":"56","author":"C Algrin","year":"2015","unstructured":"Algrin C, Faguer S, Lemiale V, Lenglin\u00e9 E, Boutboul D, Amorim S, Galicier L, Canet E, Thieblemont C, Azoulay E (2015) Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma. Leuk Lymphoma 56:1240\u20131245. https:\/\/doi.org\/10.3109\/10428194.2014.922181","journal-title":"Leuk Lymphoma"},{"key":"3496_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/CCM.0000000000001648","volume":"44","author":"K Normilio-Silva","year":"2016","unstructured":"Normilio-Silva K, de Figueiredo AC, Pedroso-de-Lima AC, Tunes-da-Silva G, Nunes da Silva A, Delgado Dias Levites A, de-Simone AT, Lopes Safra P, Zancani R, Tonini PC, Vasconcelos de Andrade e Silva U, Buosi Silva T, Martins Giorgi J, Eluf-Neto J, Costa A, Abrah\u00e3o Hajjar L, Biasi Cavalcanti A (2016) Long-term survival, quality of life, and quality-adjusted survival in critically ill patients with Cancer. Crit Care Med 44:1327\u20131337. https:\/\/doi.org\/10.1097\/CCM.0000000000001648","journal-title":"Crit Care Med"},{"key":"3496_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00134-016-4563-5","volume":"43","author":"FG Zampieri","year":"2017","unstructured":"Zampieri FG, Bozza FA, Moralez GM, Mazza DDS, Scotti AV, Santino MS, Ribeiro RAB, Rodrigues Filho EM, Cabral MM, Maia MO, D\u2019Alessandro PS, Oliveira SV, Menezes MAM, Caser EB, Lannes RS, Alencar Neto MS, Machado MM, Sousa MF, Salluh JIF, Soares M (2017) The effects of performance status one week before hospital admission on the outcomes of critically ill patients. Intensive Care Med 43:39\u201347. https:\/\/doi.org\/10.1007\/s00134-016-4563-5","journal-title":"Intensive Care Med"},{"key":"3496_CR17","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1200\/JCO.2006.05.7869","volume":"24","author":"M Soares","year":"2006","unstructured":"Soares M, Salluh JIF, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol Off J Am Soc Clin Oncol 24:4003\u20134010. https:\/\/doi.org\/10.1200\/JCO.2006.05.7869","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3496_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jcrc.2014.01.016","volume":"29","author":"C-M Park","year":"2014","unstructured":"Park C-M, Koh Y, Jeon K, Na S, Lim CM, Choi WI, Lee YJ, Kim SC, Chon GR, Kim JH, Kim JY, Lim J, Rhee CK, Park S, Kim HC, Lee JH, Lee JH, Park J, Cho J, Koh SO, Suh GY, Validation of Simplified acute physiology score 3 in Korean Intensive care unit (VSKI) study group, Korean Study Group on Respiratory Failure (KOSREF) (2014) Impact of eastern cooperative oncology group performance status on hospital mortality in critically ill patients. J Crit Care 29:409\u2013413. https:\/\/doi.org\/10.1016\/j.jcrc.2014.01.016","journal-title":"J Crit Care"},{"key":"3496_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","volume":"19","author":"FS Taccone","year":"2015","unstructured":"Taccone FS, Van den Abeele A-M, Bulpa P et al (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care Lond Engl 19:7. https:\/\/doi.org\/10.1186\/s13054-014-0722-7","journal-title":"Crit Care Lond Engl"},{"key":"3496_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","volume":"43","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA (2017) Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med 43:1225\u20131238. https:\/\/doi.org\/10.1007\/s00134-017-4731-2","journal-title":"Intensive Care Med"},{"key":"3496_CR21","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","volume":"17","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Monbrison F, le Strat Y, Coignard B, Dromer F, Bretagne S, French Mycosis Study Group (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 17:1882\u20131889. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03548.x","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"3496_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11:275\u2013288. https:\/\/doi.org\/10.1038\/nri2939","journal-title":"Nat Rev Immunol"},{"key":"3496_CR23","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3109\/10428194.2015.1106537","volume":"57","author":"P Wohlfarth","year":"2016","unstructured":"Wohlfarth P, Carlstr\u00f6m A, Staudinger T, Clauss S, Hermann A, Rabitsch W, Bojic A, Skrabs C, Porpaczy E, Schiefer AI, Valent P, Kn\u00f6bl P, Agis H, Hauswirth A, J\u00e4ger U, Kundi M, Sperr WR, Schellongowski P, Arbeitsgruppe f\u00fcr h\u00e4mato-onkologische Intensivmedizin der \u00d6sterreichischen Gesellschaft f\u00fcr Internistische und Allgemeine Intensivmedizin und Notfallmedizin (\u00d6GIAIN) (2016) Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 57:1831\u20131838. https:\/\/doi.org\/10.3109\/10428194.2015.1106537","journal-title":"Leuk Lymphoma"},{"key":"3496_CR24","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","volume":"117","author":"FM Foss","year":"2011","unstructured":"Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T-cell lymphoma. Blood 117:6756\u20136767. https:\/\/doi.org\/10.1182\/blood-2010-05-231548","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3496-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T01:49:13Z","timestamp":1571881753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3496-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"14 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by our institutional review board (CECIC Clermont Ferrand \u2013 IRB no.5891; Ref. 2007-16). According to French law, informed consent was not required in this retrospective observational study in which the collected data were anonymised.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"GD, LB, CG, SA, LZ, VL, EM, CT and EC declare that they have no competing interests. EA declares the following statements: board member for Gilead, lectures for Alexion, MSD, Astellas, and research grants from MSD, Fisher & Payckle, Pfizer (2012).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}